Klor-con m20 and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Klor-con m20 (potassium chloride), especially for people who are female, 60+ old, also take Vitamin D3, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Sepsis when taking Klor-con m20. It is created by eHealthMe based on reports of 2,228 people who have side effects when taking Klor-con m20 from the FDA, and is updated regularly.

What is Klor-con m20?

Klor-con m20 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 2,411 Klor-con m20 users. Check the latest studies of Klor-con m20.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,523 drugs and 3,259 conditions by eHealthMe. Check the latest studies of Sepsis.

On Jul, 12, 2026

2,228 people reported to have side effects when taking Klor-con m20.
Among them, 31 people (1.39%) have Sepsis.

Among these 31 people:

What is the gender of people who have Sepsis when taking Klor-con m20? *

female: 53.57 %
male: 46.43 %

What is the age of people who have Sepsis when taking Klor-con m20? *

What are other drugs people take besides Klor-con m20? *

What are other side effects people have besides Sepsis? *

Fatigue (feeling of tiredness): 9 people, 29.03%
Urinary Tract Infection: 9 people, 29.03%
Pneumonia: 8 people, 25.81%
Dyspnea (difficult or laboured breathing): 6 people, 19.35%
Weakness: 6 people, 19.35%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 19.35%
Fall: 6 people, 19.35%
Dyspnea Exertional: 6 people, 19.35%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 5 people, 16.13%
Pain: 5 people, 16.13%

What are the existing conditions these people have? *

Stress And Anxiety: 7 people, 22.58%
Pain: 6 people, 19.35%
High Blood Cholesterol: 5 people, 16.13%
Multiple Myeloma (cancer of the plasma cells): 4 people, 12.90%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 9.68%
Diarrhea: 3 people, 9.68%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.68%
Gout (uric acid crystals building up in the body): 3 people, 9.68%
Cardiac Disorder: 3 people, 9.68%
Type 2 Diabetes: 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con m20 and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con m20:

Klor-con m20 (2,411 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Klor-con m20:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,523 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con m20) and Klor-con m20 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.